Income Statement
PALISADE BIO, INC.
PALI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | 0.00 | 0.25 | - | - | - | - | - | 0.26 | 0.02 | 0.01 | 0.02 | 0.11 | 0.41 | 0.39 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | 0.25 | - | - | - | - | - | 0.26 | 0.02 | 0.01 | 0.02 | 0.11 | 0.41 | 0.39 |
|
Operating Expenses
|
18.06 | 14.86 | 13.32 | 15.72 | 41.85 | 10.69 | 8.65 | 8.52 | 13.57 | 20.65 | 19.17 | 17.45 | 12.63 | 10.56 | 13.38 |
|
Research & Development
|
10.19 | 9.06 | 6.89 | 6.55 | 2.43 | 2.02 | 4.06 | 3.96 | 8.10 | 13.16 | 12.64 | 8.13 | 7.13 | 6.11 | 7.35 |
|
Selling, General & Administrative
|
7.86 | 5.80 | 6.20 | 8.76 | 9.31 | 8.67 | 4.59 | 4.56 | 5.47 | 7.50 | 6.53 | 8.97 | 5.25 | 4.25 | 5.84 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-18.06 | -14.86 | -13.07 | -15.72 | -41.85 | -10.69 | -8.65 | -8.52 | -13.31 | -20.64 | -19.16 | -17.44 | -12.52 | -10.16 | -12.99 |
|
Non-Operating Income
|
1.28 | 0.42 | 0.77 | 1.46 | 15.24 | -5.59 | 0.28 | 3.33 | -2.36 | -0.44 | -1.75 | -5.19 | -7.31 | 0.03 | 0.47 |
|
Interest Income
|
- | - | - | - | - | 0.03 | 0.07 | 0.08 | 0.07 | 0.06 | 0.07 | 0.07 | 0.07 | 0.03 | 0.06 |
|
Interest Expense
|
- | 0.01 | 0.02 | 0.01 | 2.40 | 0.01 | 0.01 | 0.01 | 0.16 | 1.14 | 1.82 | 1.62 | 1.39 | 0.00 | 0.00 |
|
Other Non-Op Income / Expense
|
1.29 | 0.43 | 0.79 | 0.16 | 0.05 | - | - | - | - | - | 0.00 | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-16.78 | -14.44 | -12.30 | -14.26 | -26.62 | 16.27 | 8.35 | -4.92 | -15.67 | -21.07 | 0.00 | 0.00 | 0.00 | -10.12 | -12.52 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-18.06 | -14.86 | -13.07 | -15.72 | -41.85 | -10.60 | -8.50 | -8.33 | -13.02 | -20.30 | -18.81 | -17.09 | -12.28 | -9.95 | -12.80 |
|
Earnings Per Share (Basic)
|
-0.30 | -10.19 | -1.80 | -16.53 | -2.86 | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.30 | -10.19 | -1.80 | -16.53 | -3.39 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
55.67 | 1.42 | 6.84 | 0.88 | 9.31 | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
55.67 | 1.42 | 6.84 | 0.88 | 9.35 | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | -16.26 | -8.36 | -4.93 | -15.67 | -21.07 | - | - | - | - | - |